Advances in Diabetes and Thyroid Disease 2013 is a comprehensive Harvard Medical School CME activity addressing practical aspects of diabetes and thyroid disease care and management, including the use of new technologies that address the growing complexity of diabetes care and the challenges of managing chronic illness in a primary care practice.
Why You Should Attend
The majority of people with diabetes and thyroid disease are cared for by their primary care providers, so PCPs need a comprehensive review and update on clinical management to provide optimal care. This annual CME course, initiated more than century ago by Elliott P. Joslin, MD in conjunction with Harvard Medical School, is the longest-running academic course in diabetes in the United States and, likely, the world. The course has evolved with diabetes practice and research as well as the changing continuing education needs of the medical profession, incorporating participant interaction in smaller breakout sessions, interactive workshops, and question-and-answer opportunities for a dynamic learning experience.
Upon completion of this activity, participants will be able to:
- Evaluate recent advances in the pathophysiology of type 1 and type 2 diabetes, as well as comorbidities of these conditions
- Analyze advances in research related to the treatment of diabetes and related conditions that have translated into improved glucose control, complication prevention/treatment, and quality of life for people living with this condition
- Demonstrate skills in advancing therapies for glycemic control aimed at achieving recommended treatment targets
- Develop strategies to care for patients with diabetes and comorbidities based on updated knowledge of state-of-the-art treatment approaches
- Implement treatment strategies to diagnose and treat the morbidity of hyperthyroidism, secondary hyperparathyroidism, and thyroid nodules in your primary care practice.
- Summarize approaches to treatment and/or collaborative interventions for hypothyroidism, primary hyperparathyroidism, and thyroid cancers.
This course is designed to meet one or more of the following Accreditation Council of Graduate Medical Education competencies:
- Patient care
- Medical knowledge
- Practice-based learning and improvement
Accreditation and Designation of Credit
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Harvard Medical School designates this live activity for a maximum of 29.25 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS.
One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 29.25 ECMEC© Credits are available.
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Page last updated: June 16, 2019